Table 2 Site of infection and pathogenesis of patients in both groups. TBI, traumatic brain injury; MRSA, methicillin-resistant Staphylococcus aureus; MRCNS, methicillin resistant coagulase negative staphylococci; MIC, minimum inhibitory concentration.

From: Effect of traumatic brain injury on the trough concentration of linezolid in patients with hospital-acquired pneumonia

Characteristics

TBI group (n = 46)

Non-TBI group (n = 46)

Statistics

P

Sites of infection, n (%)

Pulmonary infection

46 (100.0)

46 (100.0)

Bloodstream infection

9 (19.6)

7 (15.2)

0.778

0.378

Intra-abdominal infection

2 (4.3)

2 (4.3)

> 0.999

Urinary tract infection

4 (8.7)

6 (13.0)

0.015

0.902

Skin and soft tissue infection

3 (6.5)

4 (8.7)

> 0.999

Intracranial infection

9 (19.6)

0 (0.0)

9.61

0.002

More than two sites of infection

17 (37.0)

15 (32.6)

1.071

0.301

Cases of Gram-positive bacteria, no. (Strains)

29 (38strains)

33 (41strains)

  

MRSA, n (%)

18 (47.4)

14 (34.1)

3.556

0.314

MRCNS, n (%)

10 (26.3)

8 (19.5)

Enterococcus, n (%)

5 (13.2)

11 (26.8)

Gram-positive bacillus, n (%)

5 (13.2)

8 (19.5)

Gram-negative bacteria and fungus, n (%)

Mixed with Gram-negative bacteria

24 (82.8)

23 (69.7)

1.436

0.231

Mixed with fungus

10 (34.5)

8 (24.2)

0.786

0.375

MIC of Gram-positive bacteria, n (%)

≤ 1

11 (28.9)

15 (36.6)

0.855

0.661

2

25 (65.8)

23 (56.1)

4

2 (5.3)

3 (7.3)